BAVA:CPH
Bavarian Nordic A/S
DKK 239.00
arrow_upward
+1.62%(+3.80) 1D
Okt 15, 5:00:00 PM GMT+2 · DKK
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa BAVA...
Buksan
DKK 236.00
Mataas
DKK 239.00
Mababa
DKK 234.20
Mkt. cap
18.77B
Avg. na dami
179.21K
Dami
161.65K
Mataas nang 52-wk
DKK 243.70
Mababa nang 52-wk
DKK 171.30
Mga natitirang share
79.27M
Bilang ng mga empleyado
2K
Buksan
DKK 236.00
Mataas
DKK 239.00
Mababa
DKK 234.20
Mkt. cap
18.77B
Avg. na dami
179.21K
Dami
161.65K
Mataas nang 52-wk
DKK 243.70
Mababa nang 52-wk
DKK 171.30
Mga natitirang share
79.27M
Bilang ng mga empleyado
2K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
www.marketscreener.com
·
3 araw ang nakalipas
Bavarian Nordic A/S : - Transactions in Connection with Share Buy-Back Program
Yahoo Finance
·
3 araw ang nakalipas
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program
Profile
Bavarian Nordic A/S is a Danish biotechnology company focused on the development, manufacturing and commercialization of vaccines. The company is headquartered in Hellerup, Denmark, with manufacturing facilities in Kvistgård, Denmark and Thörishaus near Bern, Switzerland. The company has research and development facilities in Martinsried, Germany, as well as offices in USA, Canada, and France. The company uses viral vectors and virus-like particles in its research and development.
In July 2025, the company agreed to be acquired by private equity firms Permira and Nordic Capital for 19 billion kr. However, in November, the acquisition failed to gain sufficient support from Bavarian Nordic's shareholders, leading to its termination.
In 2026, Bavarian Nordic was ranked second in Time Magazine's World Most Impactful Companies. Wikipedia
Tungkol sa Bavarian Nordic A/S